|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.59 CNY | +3.27% |
|
+14.55% | -6.84% |
| Market Cap | 4.39B 650M 563M 525M 483M 911M 61.82B 922M 6.17B 2.42B 30.93B 2.44B 2.39B 102B | P/E 2024 |
-22.7x | P/E 2025 | -46.3x |
|---|---|---|---|---|---|
| Enterprise Value | 4.72B 699M 605M 564M 519M 979M 66.42B 990M 6.63B 2.6B 33.23B 2.62B 2.57B 110B | EV / Sales 2024 |
6.46x | EV / Sales 2025 | 32.7x |
| Free-Float |
30.57% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +3.27% | ||
| 1 week | +14.55% | ||
| Current month | +11.58% | ||
| 1 month | -5.68% | ||
| 3 months | -33.39% | ||
| 6 months | -9.18% | ||
| Current year | -6.84% |
| 1 week | 45.21 |  | 56 |
| 1 month | 44.55 | | 66.68 |
| Current year | 44.55 | | 98.29 |
| 1 year | 34.2 | | 98.29 |
| 3 years | 12.6 | | 98.29 |
| 5 years | 12.6 | | 98.29 |
| 10 years | 12.6 | | 98.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yong Deng
CEO | Chief Executive Officer | 60 | 01/12/2018 |
Chao Li
DFI | Director of Finance/CFO | 47 | 01/05/2017 |
Fen Jin
DFI | Director of Finance/CFO | 46 | 01/12/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Ying Fei Liu
BRD | Director/Board Member | 48 | 21/02/2020 |
Yong Deng
CHM | Chairman | 60 | 01/12/2017 |
Shao Zhong Zhang
BRD | Director/Board Member | 70 | 21/02/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.27% | +14.55% | +50.77% | +121.30% | 630M | |
| +4.86% | -3.32% | +52.73% | +160.26% | 995B | |
| +1.04% | -2.99% | +50.87% | +52.38% | 614B | |
| +0.98% | -6.49% | +24.00% | +66.66% | 431B | |
| +1.96% | +0.83% | +42.80% | +37.60% | 353B | |
| -0.11% | -4.07% | +30.37% | +39.73% | 293B | |
| +2.52% | -8.36% | +7.27% | +10.32% | 245B | |
| +4.57% | +5.21% | +35.91% | +67.64% | 210B | |
| -4.32% | -12.94% | -3.79% | -44.56% | 210B | |
| -2.58% | -0.73% | +17.16% | +67.46% | 168B | |
| Average | +0.80% | -1.01% | +30.81% | +57.88% | 351.89B | |
| Weighted average by Cap. | +0.74% | -3.95% | +36.80% | +75.04% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 241M 35.64M 30.87M 28.78M 26.47M 49.96M 3.39B 50.52M 338M 133M 1.7B 134M 131M 5.62B | 154M 22.84M 19.78M 18.44M 16.96M 32.01M 2.17B 32.37M 217M 85.04M 1.09B 85.77M 83.88M 3.6B |
| Net income | -62.67M -9.28M -8.04M -7.49M -6.89M -13.01M -883M -13.16M -88.07M -34.56M -442M -34.86M -34.09M -1.46B | -102M -15.13M -13.11M -12.22M -11.24M -21.21M -1.44B -21.45M -144M -56.35M -720M -56.84M -55.59M -2.38B |
| Net Debt | 135M 19.95M 17.28M 16.11M 14.81M 27.97M 1.9B 28.28M 189M 74.29M 949M 74.93M 73.28M 3.14B | 327M 48.4M 41.92M 39.07M 35.94M 67.85M 4.6B 68.6M 459M 180M 2.3B 182M 178M 7.63B |
Employees
461
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/08/26 | CN¥55.59 | +3.27% | 1,208,439 |
| 04/08/26 | CN¥53.83 | +5.78% | 2,243,100 |
| 03/08/26 | CN¥50.89 | +2.15% | 2,308,700 |
| 31/07/26 | CN¥49.82 | +10.69% | 3,086,625 |
| 30/07/26 | CN¥45.01 | -7.25% | 1,654,701 |
- Stock Market
- Stocks
- 301075 Stock
Select your edition
All financial news and data tailored to specific country editions
